A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia

被引：0
|
作者：
Hafeez, M. [1 ]
Shaharyar, A. [1 ]
Zia, N. [1 ]
Rasheed, H. [1 ]
机构：
[1] King Edward Med Univ, Mayo Hosp, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18002
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
    Naoyuki Miyagawa
    Hiroaki Goto
    Atsushi Ogawa
    Atsushi Kikuta
    Yoshiyuki Kosaka
    Masahiro Sekimizu
    Daisuke Tomizawa
    Hidemi Toyoda
    Hidefumi Hiramatsu
    Junichi Hara
    Shinji Mochizuki
    Hideki Nakayama
    Kenichi Yoshimura
    Yuka Iijima-Yamashita
    Masashi Sanada
    Chitose Ogawa
    International Journal of Hematology, 2023, 118 : 267 - 276
  • [32] PHASE I STUDY OF MOXETUMOMAB PASUDOTOX IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
    Ravandi, F.
    Cortes, J.
    Thomas, D.
    Rytting, M.
    Daver, N.
    Konopleva, M.
    Kebriaei, P.
    Wierda, W.
    DiNardo, C.
    Bivins, C.
    Mccue, D.
    Pierce, S.
    Richie, A.
    Kantarjian, H.
    HAEMATOLOGICA, 2016, 101 : 351 - 351
  • [33] Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
    Ravandi, Farhad
    Cortes, Jorge E.
    Jones, Daniel
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    O'Brien, Susan
    Estrov, Zeev
    Borthakur, Gautam
    Thomas, Deborah
    Pierce, Sherry R.
    Brandt, Mark
    Byrd, Anna
    Bekele, B. Nebiyou
    Pratz, Keith
    Luthra, Rajyalakshmi
    Levis, Mark
    Andreeff, Michael
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1856 - 1862
  • [34] PHASE-II TRIAL OF IDARUBICIN ALONE AND IN COMBINATION WITH CYTARABINE IN PATIENTS WITH ACUTE-LEUKEMIA
    ARLIN, Z
    BERMAN, E
    DAGHESTANI, A
    GEE, T
    KEMPIN, S
    MERTELSMANN, R
    SCHULMAN, P
    BUDMAN, D
    CLARKSON, B
    YOUNG, C
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 99 - 99
  • [35] Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia
    Kaufmann, Scott H.
    Karp, Judith E.
    Litzow, Mark R.
    Mesa, Ruben A.
    Hogan, William
    Steensma, David P.
    Flatten, Karen S.
    Loegering, David A.
    Schneider, Paula A.
    Peterson, Kevin L.
    Maurer, Matthew J.
    Smith, B. Douglas
    Greer, Jacqueline
    Chen, Yuhong
    Reid, Joel M.
    Ivy, S. Percy
    Ames, Matthew M.
    Adjei, Alex A.
    Erlichman, Charles
    Karnitz, Larry M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (11): : 1619 - 1626
  • [36] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
  • [37] Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    von Stackelberg, Arend
    Locatelli, Franco
    Zugmaier, Gerhard
    Handgretinger, Rupert
    Trippett, Tanya M.
    Rizzari, Carmelo
    Bader, Peter
    O'Brien, Maureen M.
    Brethon, Benoit
    Bhojwani, Deepa
    Schlegel, Paul Gerhardt
    Borkhardt, Arndt
    Rheingold, Susan R.
    Cooper, Todd Michael
    Zwaan, Christian M.
    Barnette, Phillip
    Messina, Chiara
    Michel, Gerard
    DuBois, Steven G.
    Hu, Kuolung
    Zhu, Min
    Whitlock, James A.
    Gore, Lia
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4381 - +
  • [38] A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia
    Litzow, Mark R.
    Lee, Sandra
    Bennett, John M.
    Dewald, Gordon W.
    Gallagher, Robert E.
    Jain, Vibha
    Paietta, Elisabeth M.
    Racevskis, Janis
    Rousey, Steven R.
    Mazza, Joseph J.
    Tallman, Martin S.
    HAEMATOLOGICA, 2006, 91 (08) : 1105 - 1108
  • [39] AS1411 IN COMBINATION WITH CYTARABINE IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA
    Stuart, K.
    Stockerl-Goldstein, K.
    Cooper, M.
    Devetten, M.
    Herzig, R.
    Medeiros, B.
    Schiller, G.
    Wei, A.
    Acton, G.
    Rizzieri, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 336 - 336
  • [40] A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia
    Weiss, MA
    Aliff, TB
    Tallman, MS
    Frankel, SR
    Kalaycio, ME
    Maslak, PG
    Jurcic, JG
    Scheinberg, DA
    Roma, TE
    CANCER, 2002, 95 (03) : 581 - 587
12345